Company intelligence / Profile preview
NANO MRNA Co.,Ltd.
Tokyo, Tokyo Metropolis, Japannanomrna.co.jp ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
NANO MRNA Co.,Ltd. researches, develops, produces, and sells pharmaceuticals using proprietary micellar nanoparticle technology. The company operates within the biotechnology sector with a focus on innovative drug delivery systems. Specific clinical results are not detailed in the provided sources.
- Therapeutic areas
- Other
- Modalities
- micellar nanoparticlesmRNA-based therapeutics (inferred from company name and technology focus)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on NANO MRNA Co.,Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NANO MRNA Co.,Ltd..